Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy

Journal of Medical Genetics

Volumn 51, Issue 9, 2014, Pages 614-622

  Li, Jing ^a   Lou, Haiyi ^a   Yang, Xiong ^a   Lu, Dongsheng ^a   Li, Shilin ^b   Jin, Li ^b   Pan, Xinwei ^b   Yang, Wenjun ^c   Song, Manshu ^d   Mamatyusupu, Dolikun ^e   Xu, Shuhua ^a  

^a Chinese Academy of Sciences   (China)

^b FUDAN UNIVERSITY   (China)

^c NINGXIA MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e XINJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHINA; CHINESE; COMPARATIVE STUDY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; DRUG RESPONSE; DRUG SAFETY; GENE FREQUENCY; GENETIC DIFFERENCE; GENETIC VARIABILITY; HAN CHINESE; HAPLOTYPE; HAPLOTYPE MAP; HETEROZYGOSITY; HUI (PEOPLE); HUMAN; KAZAKH (PEOPLE); KYRGYZ (PEOPLE); MINORITY GROUP; PHENOTYPE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TAJIK (PEOPLE); UYGUR (PEOPLE); ASIAN CONTINENTAL ANCESTRY GROUP; CAUCASIAN; DOSE RESPONSE; ETHNIC GROUP; GENE FLOW; GENETIC VARIATION; GENETICS; PHARMACOKINETICS; POPULATION GENETICS;

ASIAN CONTINENTAL ANCESTRY GROUP; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FLOW; GENE FREQUENCY; GENETIC VARIATION; GENETICS, POPULATION; HAPLOTYPES; HUMANS; PHARMACOKINETICS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84907078700     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmedgenet-2014-102530     Document Type: Article

References (38)

1. Shastry BS. Pharmacogenetics and the concept of individualized medicine. Pharmacogenomics J 2006;6:16-21.
2. Sim SC, Kacevska M, Ingelman-Sundberg M. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects. Pharmacogenomics J 2013;13:1-11.
3. Li JZ, Absher DM, Tang H, Southwick AM, Casto AM, Ramachandran S, Cann HM, Barsh GS, Feldman M, Cavalli-Sforza LL, Myers RM. Worldwide human relationships inferred from genome-wide patterns of variation. Science 2008;319:1100-4.
4. Delser PM, Fuselli S. Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications. Hum Genet 2013;132:563-77.
5. Chen X, Wang H, Zhou G, Zhang X, Dong X, Zhi L, Jin L, He F. Molecular population genetics of human CYP3A locus: signatures of positive selection and implications for evolutionary environmental medicine. Environ Health Perspect 2009;117:1541-8.
6. Wooding SP, Watkins WS, Bamshad MJ, Dunn DM, Weiss RB, Jorde LB. DNA sequence variation in a 3.7-kb noncoding sequence 50 of the CYP1A2 gene: implications for human population history and natural selection. Am J Hum Genet 2002;71:528-42.
7. Sabbagh A, Darlu P, Crouau-Roy B, Poloni ES. Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey. PLoS ONE 2011;6:e18507.
8. Li J, Zhang L, Zhou H, Stoneking M, Tang K. Global patterns of genetic diversity and signals of natural selection for human ADME genes. Hum Mol Genet 2011;20:528-40.
9. Ramos E, Doumatey A, Elkahloun AG, Shriner D, Huang H, Chen G, Zhou J, McLeod H, Adeyemo A, Rotimi CN. Pharmacogenomics, ancestry and clinical decision making for global populations. Pharmacogenomics J 2014;14:217-22.
10. Yang HC, Lin CW, Chen CW, Chen JJ. Applying genome-wide gene-based expression quantitative trait locus mapping to study population ancestry and pharmacogenetics. BMC Genomics 2014;15:319.
11. Suarez-Kurtz G, Paula DP, Struchiner CJ. Pharmacogenomic implications of population admixture: Brazil as a model case. Pharmacogenomics 2014;15:209-19.
12. Xu S, Huang W, Qian J, Jin L. Analysis of genomic admixture in Uyghur and its implication in mapping strategy. Am J Hum Genet 2008;82:883-94.
13. Xu S, Jin L. A genome-wide analysis of admixture in Uyghurs and a high-density admixture map for disease-gene discovery. Am J Hum Genet 2008;83:322-36.
14. Comas D, Plaza S, Wells RS, Yuldaseva N, Lao O, Calafell F, Bertranpetit J. Admixture, migrations, and dispersals in Central Asia: evidence from maternal DNA lineages. Eur J Hum Genet 2004;12:495-504.
15. Ablimit A, Qin W, Shan W, Wu W, Ling F, Ling KH, Zhao C, Zhang F, Ma Z, Zheng X. Genetic diversities of cytochrome B in Xinjiang Uyghur unveiled its origin and migration history. BMC Genet 2013;14:100.
16. Magalon H, Patin E, Austerlitz F, Hegay T, Aldashev A, Quintana-Murci L, Heyer E. Population genetic diversity of the NAT2 gene supports a role of acetylation in human adaptation to farming in Central Asia. Eur J Hum Genet 2008;16:243-51.
17. Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu FL, Bonnen PE, de Bakker PIW, Deloukas P, Gabriel SB, Gwilliam R, Hunt S, Inouye M, Jia XM, Palotie A, Parkin M, Whittaker P, Chang K, Hawes A, Lewis LR, Ren YR, Wheeler D, Muzny DM, Barnes C, Darvishi K, Hurles M, Korn JM, Kristiansson K, Lee C, McCarroll SA, Nemesh J, Keinan A, Montgomery SB, Pollack S, Price AL, Soranzo N, Gonzaga-Jauregui C, Anttila V, Brodeur W, Daly MJ, Leslie S, McVean G, Moutsianas L, Nguyen H, Zhang QR, Ghori MJR, McGinnis R, McLaren W, Takeuchi F, Grossman SR, Shlyakhter I, Hostetter EB, Sabeti PC, Adebamowo CA, Foster MW, Gordon DR, Licinio J, Manca MC, Marshall PA, Matsuda I, Ngare D, Wang VO, Reddy D, Rotimi CN, Royal CD, Sharp RR, Zeng CQ, Brooks LD, McEwen JE, Consortium IH. Integrating common and rare genetic variation in diverse human populations. Nature 2010;467:52-8.
18. Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. An integrated map of genetic variation from 1,092 human genomes. Nature 2012;491:56-65.
19. Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, Cawley S, Hubbell E, Veitch J, Collins PJ, Darvishi K, Lee C, Nizzari MM, Gabriel SB, Purcell S, Daly MJ, Altshuler Dxz. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet 2008;40: 1253-60.
20. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 2006;78:629-44.
21. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
22. Pruitt KD, Tatusova T, Maglott DR. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 2007;35(Database issue):D61-5.
23. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010;26:2069-70.
24. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, Cherry JM, Snyder M. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012;22:1790-7.
25. Whirl-Carrillo M, McDonagh EM, Hebert JM, Gong L, Sangkuhl K, Thorn CF, Altman RB, Klein TE. Pharmacogenomics Knowledge for Personalized Medicine. Clin Pharmacol Ther 2012;92:414-17.
26. Hubisz MJ, Falush D, Stephens M, Pritchard JK. Inferring weak population structure with the assistance of sample group information. Mol Ecol Resour 2009;9:1322-32.
27. Price AL, Tandon A, Patterson N, Barnes KC, Rafaels N, Ruczinski I, Beaty TH, Mathias R, Reich D, Myers S. Sensitive detection of chromosomal segments of distinct ancestry in admixed populations. PLoS Genet 2009;5:e1000519.
28. Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet 2006;2:e190.
29. Excoffier L, Lischer HEL. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 2010;10:564-7.
30. Weir BS, Cockerham CC. Estimating F-Statistics for the Analysis of Population-Structure. Evolution 1984;38:1358-70.
31. Thomas MG, Weale ME, Jones AL, Richards M, Smith A, Redhead N, Torroni A, Scozzari R, Gratrix F, Tarekegn A, Wilson JF, Capelli C, Bradman N, Goldstein DB. Founding mothers of Jewish communities: Geographically separated Jewish groups were independently founded by very few female ancestors. Am J Hum Genet 2002;70:1411-20.
32. Voight BF, Kudaravalli S, Wen XQ, Pritchard JK. A map of recent positive selection in the human genome (vol 4, pg 154, 2006). PLoS Biol 2006;4:659.
33. Nielsen R, Williamson S, Kim Y, Hubisz MJ, Clark AG, Bustamante C. Genomic scans for selective sweeps using SNP data. Genome Res 2005;15: 1566-75.
34. Visscher H, Ross CJ, Rassekh SR, Barhdadi A, Dube MP, Al-Saloos H, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Brown AM, Rogers PC, Phillips MS, Rieder MJ, Carleton BC, Hayden MR. Canadian Pharmacogenomics Network for Drug Safety C. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol 2012;30:1422-8.
35. Perera MA, Gamazon E, Cavallari LH, Patel SR, Poindexter S, Kittles RA, Nicolae D, Cox NJ. The Missing Association: Sequencing-Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African Americans. Clin Pharmacol Ther 2011;89:408-15.
36. Chen J, Zheng H, Bei JX, Sun L, Jia WH, Li T, Zhang F, Seielstad M, Zeng YX, Zhang X, Liu J. Genetic structure of the Han Chinese population revealed by genome-wide SNP variation. Am J Hum Genet 2009;85:775-85.
37. Xu S, Yin X, Li S, Jin W, Lou H, Yang L, Gong X, Wang H, Shen Y, Pan X, He Y, Yang Y, Wang Y, Fu W, An Y, Wang J, Tan J, Qian J, Chen X, Zhang X, Sun Y, Zhang X, Wu B, Jin L. Genomic dissection of population substructure of Han Chinese and its implication in association studies. Am J Hum Genet 2009;85:762-74.
38. Pena SD. The fallacy of racial pharmacogenomics. Braz J Med Biol Res 2011;44:268-75.